One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement database.

Background: Myocardial infarction is a major cause of morbidity and mortality. Guidelines have been published to optimize medical care and involve optimization of the care pathway and hospital-city coordination.

Aims: To describe the myocardial infarction care pathway during the year following hospital discharge, and the use of and adherence to secondary prevention drugs.

Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugs.

Purpose: The aim of this study was to determine whether dosing schedule requirements impair overall cardiovascular drug adherence.

Methods: A cohort study was performed with hospitalized patients at high risk of cardiovascular disease between April and September 2011. Patients were asked whether the prescribed time for taking their statin and antiplatelet drugs created any inconvenience in their daily routine and, if so, were asked to describe the reasons.

Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database.

Aims: Current guidelines recommend the use of dual antiplatelet therapy (DAT) (aspirin+clopidogrel) for patients after acute myocardial infarction (MI). In relation to this, we sought to examine the adherence to this recommended treatment regimen in a population of patients admitted with MI and subsequent percutaneous coronary intervention (PCI).

Methods And Results: A cohort study was conducted using data from the main health insurance reimbursement database of South West France.

Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study.

Background: While the factors for poor adherence for treatment with statins have been highlighted, the impact of their combination on adherence is not clear.

Aims: To estimate adherence for statins and whether it differs according to the number of cardiovascular risk factors.

Methods: A cohort study was conducted using data from the main French national health insurance system reimbursement database.

Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention.

The prevalence of statin use is high but adherence low. For public health intervention to be rational, subpopulations of nonadherent subjects must be defined. To categorise statin users with respect to patterns of reimbursement, this study was performed using the main French health reimbursement database for the Aquitaine region of south-western France.

[Terminology used in publications of pharmacoepidemiological research in france using health insurance reimbursement databases: need for harmonisation].

The reimbursement databases of the French health insurance systems are greatly used for pharmaceoepidemiological research. However, the terminology used to describe them in subsequent articles and abstracts vary greatly and thus lead to a problem of identification during bibliograhic research or during the process of indexation in medline. In this article we have fixed the terminology used and proposed both a terminology and appropriate MeSH terms for indexation for the futur.

How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database.

Introduction: Reimbursement databases are potentially invaluable tools to develop and conduct pharmacoepidemiological studies on drug use. However, two types of factors that may influence the performance of a database can be distinguished: firstly, factors related to the constitution of the database, and secondly, factors related to the data. For the latter, we think that two are important: the presence of the drug in the database and the capacity to capture real-life use, both of which are influenced by the marketing status (e.

Pharmacoepidemiological research using French reimbursement databases: yes we can!

Purpose: To describe the reimbursement databases available in France for pharmacoepidemiological research and their use.

Methods: France has a publicly funded health system that systematically covers the population. Within this system, three main insurance schemes provide health services to citizens in France and each have their own reimbursement database.

Risk of death related to psychotropic drug use in older people during the European 2003 heatwave: a population-based case-control study.

Objective: The authors investigated the association between death of older people and use of psychotropic drugs before and during the Western European August 2003 heatwave.

Method: A retrospective population-based case-control study was conducted using the French social security insurance national database. Exposure to psychotropic drugs in cases aged 70-100 years who died before (N = 2,093) and during (N = 9,531) the August 2003 heatwave was compared with those of survivors matched for age, gender, and presence of chronic illness, by using conditional logistic regressions.

Adherence to anti-inflammatory treatment for asthma in clinical practice in France.

Objectives: This study evaluated adherence to anti-inflammatory controller medication for asthma in a French population.

Methods: This was an observational cohort study that employed data from the health insurance database for the Aquitaine region of France. Eligible subjects were aged between 15 and 45 years and had > or = 1 reimbursement claim for anti-inflammatory controller medication between December 1, 2003, and December 31, 2003.

Psychotropic drugs use and risk of heat-related hospitalisation.

Objective: To assess if use of psychotropic drugs is associated with an increased risk of admission for heat-related pathologies during a heat wave period.

Method: We conducted a matched case-control study. Cases were defined as subjects admitted to an emergency department for heat-related pathology (hyperthermia or heat stroke) over the August 2003 heat wave.